International trends in clozapine use: a study in 17 countries

Acta Psychiatrica Scandinavica
C J BachmannD Taylor

Abstract

There is some evidence that clozapine is significantly underutilised. Also, clozapine use is thought to vary by country, but so far no international study has assessed trends in clozapine prescribing. Therefore, this study aimed to assess clozapine use trends on an international scale, using standardised criteria for data analysis. A repeated cross-sectional design was applied to data extracts (2005-2014) from 17 countries worldwide. In 2014, overall clozapine use prevalence was greatest in Finland (189.2/100 000 persons) and in New Zealand (116.3/100 000), and lowest in the Japanese cohort (0.6/100 000), and in the privately insured US cohort (14.0/100 000). From 2005 to 2014, clozapine use increased in almost all studied countries (relative increase: 7.8-197.2%). In most countries, clozapine use was highest in 40-59-year-olds (range: 0.6/100 000 (Japan) to 344.8/100 000 (Finland)). In youths (10-19 years), clozapine use was highest in Finland (24.7/100 000) and in the publicly insured US cohort (15.5/100 000). While clozapine use has increased in most studied countries over recent years, clozapine is still underutilised in many countries, with clozapine utilisation patterns differing significantly between countries. Future re...Continue Reading

References

Sep 27, 1975·Lancet·J Idänpään-HeikkiläI Palva
Aug 1, 1995·Psychiatric Services : a Journal of the American Psychiatric Association·M G Juarez-ReyesW A Hargreaves
Oct 1, 1996·International Journal of Technology Assessment in Health Care·L Romanucci-Ross
Nov 26, 1998·The British Journal of Psychiatry : the Journal of Mental Science·P Tharyan
Jun 7, 2006·Psychiatric Services : a Journal of the American Psychiatric Association·David J Rissmiller, Joshua H Rissmiller
Aug 28, 2007·The Psychiatric Clinics of North America·Troy A MooreAlexander L Miller
May 16, 2008·Epidemiologic Reviews·John McGrathJoy Welham
Jan 24, 2009·Journal of Psychopharmacology·J NielsenD Taylor
Dec 8, 2009·Basic & Clinical Pharmacology & Toxicology·Kari FuruHenrik Toft Sørensen
Mar 20, 2010·Journal of Medical Economics·Edward KimJohn A Bates
Jul 6, 2010·Revue D'épidémiologie Et De Santé Publique·P TuppinY Merlière
Aug 3, 2011·European Journal of Clinical Pharmacology·Yasuo TakahashiSatoshi Asai
Sep 2, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Josep Maria HaroPeter B Jones
Oct 6, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Saeed Farooq, Mark Taylor
Oct 22, 2011·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Tamara PringsheimScott B Patten
Jan 21, 2012·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·Jorge E Machado-AlbaMónica Johanna Solarte Gómez
Apr 17, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Jimmi NielsenDavid Taylor
May 9, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Antonio ClavennaMaurizio Bonati
Sep 8, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Oliver D HowesDavid Taylor
Mar 2, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Jessica L GörenMark S Bauer
Jun 15, 2013·Expert Review of Pharmacoeconomics & Outcomes Research·Sipke T VisserMaarten J Postma
Aug 27, 2013·Journal of the American Academy of Child and Adolescent Psychiatry·Jon McClellanUNKNOWN American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI)
Sep 6, 2013·Acta Psychiatrica Scandinavica·S GeeD Taylor
Sep 10, 2013·Child and Adolescent Psychiatric Clinics of North America·David I DriverJudith L Rapoport
Nov 16, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·T Scott StroupMark Olfson
Mar 25, 2014·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·F Hoffmann, C J Bachmann
Apr 9, 2014·BMC Psychiatry·Stephanie Warnez, Silvia Alessi-Severini
May 9, 2014·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Scott R ClarkHarry Hustig
Sep 11, 2014·Drugs & Aging·Henry C NdukwePrasad S Nishtala
Oct 3, 2014·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Georg SchomerusMatthias C Angermeyer
Feb 12, 2015·JAMA Psychiatry·Elizabeth Reisinger WalkerBenjamin G Druss
Mar 15, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Carolina SchneiderSophia Frangou
Apr 14, 2015·Acta Psychiatrica Scandinavica·K J RonaldsonJ J McNeil
May 29, 2015·Acta Psychiatrica Scandinavica·P ManuC U Correll
May 29, 2015·European Child & Adolescent Psychiatry·Daniele PiovaniMaurizio Bonati
Jun 20, 2015·Pharmacopsychiatry·T ForresterS Hollingworth

❮ Previous
Next ❯

Citations

May 23, 2018·Acta Psychiatrica Scandinavica·N MylesD Siskind
Jun 15, 2018·Acta Psychiatrica Scandinavica·A TanskanenH Taipale
Oct 20, 2018·Journal of Clinical Psychopharmacology·Susanne MudraMichael Schulte-Markwort
Nov 28, 2018·Irish Journal of Psychological Medicine·J Lally, F Gaughran
Mar 3, 2019·Drug and Therapeutics Bulletin·Taylan YukselenHarvey Wickham
Mar 31, 2019·British Journal of Clinical Pharmacology·Mikkel HøjlundChristoph U Correll
May 21, 2019·International Clinical Psychopharmacology·Jonathan G LeungBrian A Palmer
Mar 19, 2019·International Clinical Psychopharmacology·Eromona WhiskeyDavid Taylor
May 17, 2019·International Clinical Psychopharmacology·Cristián I MenaAlfonso A González-Valderrama
Jul 3, 2019·The International Journal of Neuropsychopharmacology·Sermin TotoAlexandra Neyazi
Oct 12, 2019·Acta Psychiatrica Scandinavica·J M Rubio, J M Kane
Jan 21, 2020·The Australian and New Zealand Journal of Psychiatry·Dan SiskindSteve Kisely
Apr 17, 2020·Journal of Psychopharmacology·Roberta RowntreeMary Clarke
Apr 9, 2020·Acta Psychiatrica Scandinavica·H Verdoux, C Quiles
Oct 7, 2017·Current Opinion in Hematology·Michał Wiciński, Mateusz M Węclewicz
Aug 2, 2018·Therapeutic Advances in Psychopharmacology·Daniel Hayes, Marinos Kyriakopoulos
Jun 27, 2018·Frontiers in Psychiatry·Yvonne C van der ZalmJean Paul Selten
Oct 31, 2018·Acta Psychiatrica Scandinavica·Ellis Onwordi, Oliver Howes
Feb 12, 2019·Pharmacoepidemiology and Drug Safety·Keval DabbaIan Maidment
Jun 17, 2020·Therapeutic Advances in Psychopharmacology·Siobhan GeeDavid Taylor
Jul 31, 2020·Therapeutic Advances in Psychopharmacology·Siobhan Gee, David Taylor
Apr 24, 2018·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Alexander Panickacheril JohnArun Dominic
Jun 25, 2018·International Journal of Clinical Pharmacy·Yuh-Lin Gan, Claire L O'Reilly
May 15, 2019·American Journal of Therapeutics·Vivekananda RachamalluManish Aligeti
Jul 9, 2020·Journal of Clinical Psychopharmacology·Oddur IngimarssonEngilbert Sigurdsson
Jan 25, 2020·Acta Psychiatrica Scandinavica·R JonesR Upthegrove
Jun 27, 2019·Journal of Psychopharmacology·Katherine BeckOliver D Howes
Mar 20, 2020·Administration and Policy in Mental Health·Y C van der ZalmUNKNOWN CLOZ-NP Study Group
May 19, 2020·General Psychiatry·Tom Varghese MLekshmi Rita Venugopal
Dec 18, 2020·Nordic Journal of Psychiatry·Heidi TaipaleMarkku Lähteenvuo
Dec 5, 2020·Acta Psychiatrica Scandinavica·Yuji YadaNorihito Yamada
Jan 20, 2021·Expert Review of Clinical Pharmacology·Georgios SchoretsanitisJose de Leon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Journal of the American Academy of Child and Adolescent Psychiatry
Mark OlfsonTobias Gerhard
The New Zealand Medical Journal
Robin M Norris
© 2022 Meta ULC. All rights reserved